Starpharma in Nanotechnology (SPHRY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Starpharma in Nanotechnology (SPHRY)

SPHRY 2.400

+14.3%

12:02 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: expatmike who wrote (5)	10/4/2008 4:59:02 PM
From: MJ	of 9

Yes, still holding!! "Starpharma is also commercialising Vivagel as a standalone product to prevent the transmission of sexually transmitted diseases, such as HIV and herpes, to be sold both in developing countries and in major western markets such as the US. These programs are being funded by the NIH grants of US$26 million. The company has a collaborative deal with another unnamed condom manufacturer for developing countries outside of the regions covered in the SSL deal." Welcome to SI, see this is your first post. What else are you following? mj

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next